Profile
Kimberley S.
Gannon worked as a Senior Director-Biology at Predix Pharmaceuticals, Inc., Senior VP-Preclinical Research & Development at Proclara Biosciences, Inc., Vice President-Research & Development at Ischemix, Inc., Head-US Operations at Eolas Biosciences Co., Ltd., and Chief Scientific Officer at Lysogene SA. She received a doctorate degree from Florida State University in 1994.
Former positions of Kimberley S. Gannon
| Companies | Position | End |
|---|---|---|
| LYSOGENE | Chief Tech/Sci/R&D Officer | 02/05/2018 |
Eolas Biosciences Co., Ltd. | Corporate Officer/Principal | - |
Ischemix, Inc.
Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs | Corporate Officer/Principal | - |
Predix Pharmaceuticals, Inc.
Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Developes novel drugs and other related products | Corporate Officer/Principal | - |
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Provides treatment of chronic neurodegenerative diseases | Chief Tech/Sci/R&D Officer | - |
Training of Kimberley S. Gannon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Predix Pharmaceuticals, Inc.
Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Developes novel drugs and other related products | Health Technology |
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Provides treatment of chronic neurodegenerative diseases | Health Technology |
Florida State University
Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ischemix, Inc.
Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs | Health Technology |
Eolas Biosciences Co., Ltd. | |
Lysogene SA
Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
- Stock Market
- Insiders
- Kimberley S. Gannon
















